Analysis of more than 100,000 FNA samples, including both benign and malignant thyroid nodules, identified 895 instances of NTRK, RET, ALK and BRAF fusions, representing potentially actionable kinase fusions. This evidence concerns the gene BRAF and thyroid nodule.